Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 75.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.02% |
| Dec 31, 2025 | 69.58% |
| Sep 30, 2025 | 33.41% |
| Jun 30, 2025 | -13.70% |
| Mar 31, 2025 | -11.93% |
| Dec 31, 2024 | -18.36% |
| Sep 30, 2024 | -17.46% |
| Jun 30, 2024 | 44.14% |
| Dec 31, 2017 | 372.06% |
| Sep 30, 2017 | 2,241.35% |
| Jun 30, 2017 | -1,105.60% |
| Mar 31, 2017 | -2,213.41% |
| Dec 31, 2016 | -119.80% |
| Sep 30, 2016 | -115.34% |
| Jun 30, 2016 | -111.63% |
| Mar 31, 2016 | -100.21% |
| Dec 31, 2015 | -91.55% |
| Sep 30, 2015 | 237.96% |
| Jun 30, 2015 | -87.80% |
| Mar 31, 2015 | 1,994.32% |
| Dec 31, 2014 | 3,316.51% |
| Sep 30, 2014 | -126.59% |
| Jun 30, 2014 | 1,269.29% |
| Mar 31, 2014 | -188.32% |
| Dec 31, 2013 | -134.87% |